Immune cell crosstalk in obesity: A key role for costimulation?

Diabetes

Volumn 63, Issue 12, 2014, Pages 3982-3991

  Seijkens, Tom ^a   Kusters, Pascal ^a   Chatzigeorgiou, Antonios ^b   Chavakis, Triantafyllos ^b   Lutgens, Esther ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD137 ANTIGEN; CD137 LIGAND; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE ANTIGEN; ADIPOCYTOKINE; CYTOKINE; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ARTICLE; CELL INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIVER; NONHUMAN; OBESITY; PATHOGENESIS; T LYMPHOCYTE; ADIPOCYTE; ANTIGEN PRESENTING CELL; IMMUNOLOGY; INSULIN RESISTANCE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANTIGEN-PRESENTING CELLS; COSTIMULATORY AND INHIBITORY T-CELL RECEPTORS; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; NEUTROPHILS; OBESITY; RECEPTOR CROSS-TALK; T-LYMPHOCYTES;

EID: 84911891418     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0272     Document Type: Article

References (77)

1. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012;18:363-374
2. Ebstein W. Zur therapie des diabetes mellitus, insbesondere über die anwendung des salicylsauren natron bei demsellben. Berliner Klinische Wochenschrift 1876;13:337-340 [in German]
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
4. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011;29:415-445
5. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013;17:851-859
6. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808
8. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-184
9. Patsouris D, Li P-P, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008;8:301-309
10. Phieler J, Chung K-J, Chatzigeorgiou A, et al. The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J Immunol 2013;191:4367-4374
11. Talukdar S, Oh Y, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012;18:1407-1412
12. Wu D, Molofsky AB, Liang H-E, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011;332:243-247
13. Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009;15:940-945
14. Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15:921-929
15. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009;15:930-939
16. Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012;55:2583-2592
17. Priceman SJ, Kujawski M, Shen S, et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 2013;110:13079-13084
18. Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-920
19. Cipolletta D, Feuerer M, Li A, et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012;486:549-553
20. Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013;145:366-374
21. Kotas ME, Lee H-Y, Gillum MP, et al. Impact of CD1d deficiency on metabolism. PLoS One 2011;6:e25478
22. Ji Y, Sun S, Xu A, et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 2012;287:13561-13571
23. Schipper HS, Rakhshandehroo M, van de Graaf SFJ, et al. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest 2012;122:3343-3354
24. Strodthoff D, Lundberg AM, Agardh HE, et al. Lack of invariant natural killer T cells affects lipid metabolism in adipose tissue of diet-induced obese mice. Arterioscler Thromb Vasc Biol 2013;33:1189-1196
25. Martin-Murphy BV, You Q, Wang H, et al. Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding. PLoS One 2014;9:e80949
26. Mantell BS, Stefanovic-Racic M, Yang X, Dedousis N, Sipula IJ, O'Doherty RM. Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS One 2011;6:e19831
27. Ohmura K, Ishimori N, Ohmura Y, et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010;30:193-199
28. Satoh M, Andoh Y, Clingan CS, et al. Type II NKT cells stimulate dietinduced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012;7:e30568
29. Wu L, Parekh VV, Gabriel CL, et al. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A 2012;109:E1143-E1152
30. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011;17:610-617
31. Kintscher U, Hartge M, Hess K, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304-1310
32. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and coinhibition. Nat Rev Immunol 2013;13:227-242
33. Bertola A, Ciucci T, Rousseau D, et al. Identi fication of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012;61:2238-2247
34. Morris DL, Cho KW, Delproposto JL, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013;62:2762-2772
35. Deng T, Lyon CJ, Minze LJ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013;17:411-422
36. Winer DA, Winer S, Chng MHY, Shen L, Engleman EG. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci 2014;71:1033-1043
37. Gerdes N, Zirlik A. Co-stimulatory molecules in and beyond co-stimulation - tipping the balance in atherosclerosis? Thromb Haemost 2011;106:804-813
38. Seijkens T, Kusters P, Engel D, Lutgens E. CD40-CD40L: linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. Diab Vasc Dis Res 2013;10:115-122
39. Engel D, Seijkens T, Poggi M, et al. The immunobiology of CD154-CD40- TRAF interactions in atherosclerosis. Semin Immunol 2009;21:308-312
40. Rudd CE, Taylor A, Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009;229:12-26
41. Dong C, Juedes AE, Temann UA, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001;409:97-101
42. Shilling RA, Bandukwala HS, Sperling AI. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease? Clin Immunol 2006;121:13-18
43. Okazaki T, Wang J. PD-1/PD-L pathway and autoimmunity. Autoimmunity 2005;38:353-357
44. Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996;8:765-772
45. Poggi M, Engel D, Christ A, et al. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler Thromb Vasc Biol 2011;31:2251-2260
46. Chatzigeorgiou A, Seijkens T, Zarzycka B, et al. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance [published correction appears in Proc Natl Acad Sci U S A 2014;111:4644]. Proc Natl Acad Sci U S A 2014;111:2686-2691
47. Ishii N, Takahashi T, Soroosh P, Sugamura K. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol 2010;105:63-98
48. Tu TH, Kim CS, Goto T, Kawada T, Kim B-S, Yu R. 4-1BB/4-1BBL interaction promotes obesity-induced adipose inflammation by triggering bidirectional inflammatory signaling in adipocytes/macrophages. Mediators Inflamm 2012;2012:972629
49. Kim C-S, Kim JG, Lee B-J, et al. Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders. Diabetes 2011;60:3159-3168
50. Denoeud J, Moser M. Role of CD27/CD70 pathway of activation in immunity and tolerance. J Leukoc Biol 2011;89:195-203
51. Kim H-J, Kim H-M, Kim C-S, et al. HVEM-deficient mice fed a high-fat diet are protected from adipose tissue inflammation and glucose intolerance. FEBS Lett 2011;585:2285-2290
52. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, et al. Dual role of B7 costimulation in obesity-related non-alcoholic steatohepatitis and metabolic dysregulation. Hepatology 2014;60:1196-1210
53. Zhong J, Rao X, Braunstein Z, et al. T-cell costimulation protects obesityinduced adipose inflammation and insulin resistance. Diabetes 2014;63:1289-1302
54. Zeng M, Guinet E, Nouri-Shirazi M. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells. Transpl Immunol 2009;20:171-179
55. Fujii M, Inoguchi T, Batchuluun B, et al. CTLA-4Ig immunotherapy of obesityinduced insulin resistance by manipulation of macrophage polarization in adipose tissues. Biochem Biophys Res Commun 2013;438:103-109
56. Smeets E, Meiler S, Lutgens E. Lymphocytic tumor necrosis factor receptor superfamily co-stimulatory molecules in the pathogenesis of atherosclerosis. Curr Opin Lipidol 2013;24:518-524
57. Poggi M, Jager J, Paulmyer-Lacroix O, et al. The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009;52:1152-1163
58. Baena-Fustegueras JA, Pardina E, Balada E, et al. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery. JAMA Surg 2013;148:151-156
59. Klein D, Timoneri F, Ichii H, Ricordi C, Pastori RL. CD40 activation in human pancreatic islets and ductal cells. Diabetologia 2008;51:1853-1861
60. Missiou A, Wolf D, Platzer I, et al. CD40L induces inflammation and adipogenesis in adipose cells - a potential link between metabolic and cardiovascular disease. Thromb Haemost 2010;103:788-796
61. Wolf D, Jehle F, Ortiz Rodriguez A, et al. CD40L deficiency attenuates dietinduced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies [published correction appears in PLoS One 2012;7: doi:10.1371/annotation/84102aae-770a-41ae-9c15-4736ed129c17]. PLoS One 2012;7:e33026
62. Wolf D, Jehle F, Michel NA, et al. Coinhibitory suppression of T cell activation by CD40 protects from obesity and adipose tissue inflammation in mice. Circulation 2014;129:2414-2425
63. Guo C-A, Kogan S, Amano SU, et al. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance. Am J Physiol Endocrinol Metab 2013;304:E951-E963
64. Jabara HH, Angelini F, Brodeur SR, Geha RS. Ligation of CD46 to CD40 inhibits CD40 signaling in B cells. Int Immunol 2011;23:215-221
65. Vinay DS, Kwon BS. Role of 4-1BB in immune responses. Semin Immunol 1998;10:481-489
66. Tu TH, Kim CS, Kang JH, et al. Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters. Int J Obes (Lond) 2014;38:1075-1082
67. Kim C-S, Tu TH, Kawada T, Kim B-S, Yu R. The immune signaling molecule 4-1BB stimulation reduces adiposity, insulin resistance, and hepatosteatosis in obese mice. Endocrinology 2010;151:4725-4735
68. Bassols J, Moreno-Navarrete JM, Ortega F, Ricart W, Fernandez-Real JM. LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes. Int J Obes (Lond) 2010;34:146-156
69. Kim H-M, Jeong C-S, Choi H-S, Kawada T, Yu R. LIGHT/TNFSF14 enhances adipose tissue inflammatory responses through its interaction with HVEM. FEBS Lett 2011;585:579-584
70. Lo JC, Wang Y, Tumanov AV, et al. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 2007;316:285-288
71. Seijkens T, Engel D, Tjwa M, Lutgens E. The role of CD154 in haematopoietic development. Thromb Haemost 2010;104:693-701
72. Kawai T, Andrews D, Colvin R, Sachs D, Cosimi A. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000;6:114
73. Kasran A, Boon L, Wortel CH, et al. Safety and tolerability of antagonist antihuman CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease. Aliment Pharmacol Ther 2005;22:111-122
74. Hassan SB, Sørensen JF, Olsen BN, Pedersen AE. Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials. Immunopharmacol Immunotoxicol 2014;36:96-104
75. Kremer JM, Peterfy C, Russell AS, et al. Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial. J Rheumatol 2014;41:1077-1087
76. Leibler C, Matignon M, Pilon C, et al. Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells. Am J Transplant 2014;14:1173-1182
77. Snanoudj R, Zuber J, Legendre C. Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits. Drugs 2010;70:2121-2131